These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.
456 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.
Sandoz Inc. recalled 263 vials of Cyclophosphamide Injection on September 5, 2025. The recall follows cGMP deviations related to temperature excursions during transportation. Healthcare providers and consumers must stop using the product immediately.
URMYWO recalled baby loungers on September 4, 2025, due to suffocation and fall hazards. The loungers violate safety standards, posing risks of serious injury or death. Consumers should stop using the product immediately and contact Pomona for a refund.
StopBox USA recalled AR-15 Chamber Lock Pro firearm locks on September 4, 2025. A manufacturing defect allows unauthorized access to firearms, posing a risk of serious injury or death. Consumers should immediately stop using the locks and contact StopBox for refunds or replacements.
Zydus Pharmaceuticals recalled 4,344 bottles of Entecavir Tablets on September 4, 2025. The recall stems from failed impurity and degradation specifications. Consumers should stop using the product immediately.
Zydus Pharmaceuticals recalled 4,440 bottles of Entecavir Tablets on September 4, 2025. The recall follows failure to meet impurity and degradation specifications. Consumers should stop using the affected tablets immediately and contact their healthcare provider.
Endico Potatoes Inc recalled 335 cases of frozen peas and carrots on September 3, 2025. The products may contain Listeria monocytogenes, a bacteria that can cause serious illness. The affected items were distributed in several states including New York and Florida.
Endico Potatoes Inc recalled 280 cases of mixed vegetables on September 3, 2025. The frozen product may be contaminated with Listeria monocytogenes. It was distributed in New York, New Jersey, Connecticut, Florida, Pennsylvania, Maryland, and Washington, D.C.
Philips Medical Systems Nederland B.V. recalled 268 Allura Xper FD20 Biplane systems on September 3, 2025. The recall affects units distributed globally due to potential failures in internal components. If malfunction occurs, motorized movements will be disabled, posing risks to operational efficiency.
Philips Medical Systems Nederland B.V. recalled 75 Allura Xper FD20/20 imaging systems on September 3, 2025. The recall affects systems due to internal component deterioration, which can hinder motorized movements. All users must stop using the device immediately and follow manufacturer instructions for safe handling.
Philips Medical Systems Nederland B.V. recalled 98 radiology imaging systems on September 3, 2025. The recall stems from internal component deterioration that may hinder motorized movements. Patients and healthcare providers must stop using the devices immediately.
Philips Medical Systems Nederland B.V. recalled five Biplane OR Tables on September 3, 2025, due to potential failure of internal components. The recall affects models 722020 and 722025, distributed worldwide. Users must stop using the affected devices immediately to avoid operational issues.
Philips Medical Systems Nederland B.V. recalled two operating room tables on September 3, 2025. The recall affects models 722022 and 722033 due to potential system failures. The malfunction can inhibit motorized movements, posing a risk to patients and healthcare providers.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 100-count bottles of 50 mg tablets due to excessive levels of N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and contact health providers for guidance.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects products with NDC 16714-050-01 due to high levels of a chemical impurity. Consumers should stop using the tablets immediately and contact healthcare providers.
Philips Medical Systems Nederland B.V. recalled 46 imaging systems on September 3, 2025. Deterioration of internal components may lead to loss of motorized movements. Healthcare providers must stop using the systems immediately and follow recall instructions.
Philips Medical Systems Netherlands B.V. recalled 1,117 X-ray imaging systems on September 3, 2025. The recall affects product codes 722010, 722026, and 722003 due to potential internal component deterioration. This issue may render motorized movements inoperable, posing a risk to patient care.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 25 mg tablets due to high levels of N-Nitroso Desmethyl Chlorpromazine. Consumers must stop using the product immediately.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20/15 OR Table on September 3, 2025. The recall affects one unit distributed worldwide, including the U.S. Systems may not perform as intended due to internal component deterioration.
Philips Medical Systems Nederland B.V. recalled 45 Allura Xper FD20/10 imaging systems on September 3, 2025. The systems may fail due to internal component deterioration, posing a high risk to users. Affected units include 11 in the U.S. and 34 internationally.
Philips Medical Systems recalled 286 Allura Xper FD10/10 imaging systems on September 3, 2025. The recall affects models 722011, 722027, and 722005 due to potential failure of internal components. This malfunction could inhibit motorized movements, posing risks to patient safety.